Inventor · disambiguated record
Guillaume Barbe
Also filed as: BARBE GUILLAUME
3 granted patents·5 pending applications·1 citations·filing 2017–2023
52Inventor score
Files withNOVARTIS AG3UMBRA THERAPEUTICS INC2HYKU BIOSCIENCES INC1RAREFIED BIOSCIENCES INC1RHEOS MEDICINES INC1
Top patents by PatentIndex Score
8 records- 0179US10844055B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2019·Granted Nov 24, 2020·1 cites·15 claims
- 0267US11530213B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2020·Granted Dec 20, 2022·0 cites·16 claims
- 0361US10266531B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2017·Granted Apr 23, 2019·0 cites·23 claims
- 0461US2024165239A1Covalent Binding Compounds for the Treatment of DiseaseHYKU BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0560US2023406854A1Covalent kras-binding compounds for therapeutic purposesUMBRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0660US2023406853A1Covalent cdk2-binding compounds for therapeutic purposesUMBRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0754US2025326738A1MALT1 Modulators and Uses ThereofRAREFIED BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0846US2023391781A1Malt1 modulators and uses thereofRHEOS MEDICINES INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guillaume Barbe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →